Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel sertraline composition for mood disorders

May 3, 1996

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

Eisai returns sumatriptan rights to Glaxo Wellcome

May 3, 1996

Phase III data for Quadramet presented at ASCO

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

Promising clinical results reported for CRF

April 26, 1996

NMDA/glycine-site antagonists revealed by RPR

April 26, 1996

Lilly claims mGluR antagonists for neurodegeneration

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...